A UPLC−MS/MS method was used to assess sixteen bile acids, including cholic acid (CA), chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), α-muricholic acid (α-MCA), β-muricholic acid (β-MCA), ursodeoxycholic acid (UDCA), hyodeoxycholic acid (HDCA), lithocholic acid (LCA), taurocholic acid (TCA), glycocholic acid (GCA), taurodeoxycholic acid (TDCA), glycodeoxycholic acid (GDCA), tauro-α-muricholic acid/tauro-β-muricholic acid (Tα-MCA/Tβ-MCA), tauroursodeoxycholic acid (TUDCA), glycoursodeoxycholic acid (GUDCA), taurohyodeoxycholic acid (THDCA) and taurolithocholic acid (TLCA), in cecal and colonic contents. After thawing at 4 °C for 30 min, the sample (~50 mg) was placed in a 1.5-mL centrifuge tube and weighed accurately. A total of 200 μL of water was added to a test tube, and the mixture was ultrasonicated for 5 min. Then, 1 mL of methanol was added. The sample was vortexed for 5 min followed by ultrasonic treatment for 1 h and centrifugation (4 °C, 12,000 rpm) for 5 min. The supernatant (100 μL) and isotope standard solutions (10 μL, 2 μg/mL CA-d4 and LCA-d4) were loaded into a 1.5-mL centrifuge tube and vortexed for 2 min. The mixture was then transferred to vials for LC−MS/MS testing. A Waters ACQUITY UPLC I-CLASS chromatograph (Waters, Milford, USA) equipped with a UPLC BEH Amide column (2.1 mm × 100 mm, 1.7 μm, Waters, USA) was used for separation. The column temperature was 50 °C. The mobile phase consisted of water/acetonitrile (10:1, v/v, containing 1 mmol/L ammonium acetate, phase A) and acetonitrile/isopropanol (1:1, v/v, phase B) with a flow rate of 0.26 mL/min. Analyte isolation was performed by elution gradient, and the injection volume was 5.0 μL. The MS data were collected using a QTRAP 6500+ LOW MASS system (AB Sciex, Framingham, MA, USA) in negative ion mode. The analysis was performed based on the following parameters: ion source voltage 2.0 kV, ion source temperature 150 °C, desolvation temperature 600 °C, desolvation gas flow 1000 L/h, cone voltage 21 V, cone gas flow 10 L/h.
Total bile acid concentrations were calculated as the sum of the concentrations of all sixteen bile acids. The primary BAs included CA, TCA, GCA, CDCA, α-MCA, β-MCA, and Tα-MCA/Tβ-MCA. The secondary BAs included DCA, GDCA, LCA, HDCA, UDCA, TLCA, THDCA, GUDCA, and TUDCA. 12α-Hydroxylated bile acids (12α-OH BAs) included CA, DCA, TCA, GCA, GDCA, and TDCA. Non-12α-hydroxylated bile acids (non-12α-OH BAs) included CDCA, α-MCA, β-MCA, LCA, HDCA, UDCA, Tα-MCA/Tβ-MCA, TLCA, THDCA, GUDCA, and TUDCA. The concentrations of primary BAs, secondary BAs, 12α-OH BAs, and non-12α-OH BAs were calculated based on the sum of the concentrations of each type of bile acid mentioned above.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.